Abstract:To construct HBV and HCV-specific HLA-A2-peptide tetramers, and to direct clinical therapy.Recombinant class I HLA-A2 heavy chains and beta-2 M were produced in Escherichia coli cells transformed with pBV220 vectors. Only the extracellular domain of class I heavy chain was expressed, following modification by replacement of the C-terminal domain with a substrate sequence for BirA biotinylation. HLA-A2-BSP was folded in the presence of beta-2 microglobulin and a specific peptide to form a peptide-MHC complex. The MHC complexes were biotinylated using purified BirA enzyme. Biotinylated MHC-peptide complexes were purified. Tetramers were generated by mixing biotinylated protein complex with streptavidin-PE at a molar ratio of 4:1. Then analysis of stained PBMCs was performed using FACScan and CellQuest software.The expression levels of pBV220-HLA-A2-BSP and beta-2M were 46% and 48% of total bacterial proteins estimated from SDS - PAGE, respectively. And they were mainly located in the insoluble fraction of the cell as inclusion bodies and the proportion were about 85% and 90%, respectively. The purity of pBV220-HLA-A2-BSP and beta-2M was above 95% analyzed by SDS-PAGE, and the concentration of pBV220-HLA-A2-BSP and beta-2M was about 1.5 g/L and 1.2 g/L, respectively. Using the constructed HLA-A2-peptide tetramer to detect the HBV/HCV-specific CTL, the HBV-specific CD8(+) frequencies were 1.84% and 0.02% - 0.68% of the total CD8(+) T cells in acute and chronic HBV hepatitis, respectively. As an additional control, an HLA-A2/HCV tetramer was tested in the acute and chronic HBV hepatitis. The frequencies never exceeded 0.02% of the total CD8(+) T cell number. Similar low levels of background staining were also detected in the HLA-A2(+) or A2(-) healthy control. The HCV-specific CD8(+) frequency was 0.02 - 0.72% of the total CD8(+) T cells in chronic HCV hepatitis. The same frequencies of control were detected.High-efficient expressions of HLA-A0201-BSP and beta-2m proteins lay a good foundation for further expression and purification in prokaryotic system and constructing MHC class I-peptide tetramer complexes to study the function of CTLs. Especially, using these two HBV and HCV-specific tetramer can detect the frequencies of the HBV/HCV-specific CD8(+) T cells directly in vitro.

Construction , expression and purification of recombinant HBcAg-MAGE-A 3 therapeutic cancer vaccine

Cloning and prokaryotic expression of tumor antigen MAGE-A9

Construction and Expression of a Humanoral Recombinant Immunotoxin Against Hepatocellular Carcinoma and Its Killing Effect on HCC Cell Line

[Construction and Prokaryotic Expression of Recombinant Gene EGFRvIII HBcAg and Immunogenicity Analysis of the Fusion Protein].

Construction and Identification of Recombinant Lentiviral Vector Containing Human MAGE-A3 Gene and Its Expression in Lung Cancer Cells

Construction and expression of recombinant eukaryotic expression vector containing hepatitis B virus surface antigen gene

Construction and Expression of Vector Containing Hepatitis B Virus Surface Antigen Gene and CpG Motifs

Construction of DNA vaccine encoding ubiquitinated HBcAg against hepatitis B virus

Anti-gastric cancer immunity of MAGE-3 retrogen-transfected dendritic cells

[Construction, Expression and Activity of a Single Chain Antibody to Gastric Cancer Cells].

[Construction of Eukaryotic Expression Vector Expressing Hepatitis B Virus HBsAg and EGFP Fusion Protein and Establishment of Stable Transfected Chang Liver Cell Line].

Construction of HLA-A2-peptide tetramer and application in HBV/HCV infection]

THE RECOMBINANT ANTI-MAGE-A1 IMMUNOTOXIN INHIBITED THE GROWTH OF HEPTACELLULAR CARCINOMA CELL BEL7402

Construction and Identification of Eukaryotic Expression Vector Pcdna3.1 (+)-ABCG2

Identification of Two Naturally Presented MAGE Antigenic Peptides from a Patient with Hepatocellular Carcinoma by Mass Spectrometry.

Construction of a novel DNA vaccine against β-hCG and its anti-tumor effects combined with adjuvant GM-CSF

Fusion of TGF-beta 1 Antigenic Determinant and HBV Core Antigen As an Anti-Tgf-beta 1 Vaccine

Construction and Characterization of Hgm-Csf-expressing K-562 Cell Line

Expression, Purification, and Renaturation of a Recombinant Peptide-Based HIV Vaccine in Escherichia Coli.

[Construction of Fusion Gene Vaccine of WT1 Multi-Epitope Fused with Stimulating Epitope of Mycobacterium Tuberculosis Heat Shock Protein 70 and Its Expression and Immunogenicity].

CONSTRUCTION AND IMMUNOGENICITY OF Hcg CHIMERIC PEPTIDES (CP1 and CP10) CONTAINING THREE SELF- B CELL EPITOPES AND SIX FOREIGN T CELL EPITOPES